Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-10-12

Clinical Trial Update: Glucose Regulation During Risperidone and Olanzapine Treatment [NA]

View source ↗

Summary

A clinical trial update assessing glucose regulation during treatment with risperidone and olanzapine in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal (risperidone)
  • Zyprexa (olanzapine)

Snippet

Sponsor: National Center for Research Resources (NCRR) | Conditions: Schizophrenia | NA | Status: UNKNOWN